Cynata Receives US$3 million Fujifilm License Fee
Filed with ASX · · 1 page · English
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Fujifilm Exercises License Option in GvHD
- Update on Discussions with Sumitomo and Fujifilm
- Response to ASX Aware Query
- Response to ASX Price and Volume Query
- Cynata confirms receipt of indicative non-binding proposal
Later from Cynata Therapeutics
- CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial
- Cynata & Sumitomo Withdraw from Acquisition Discussions
- September 2019 Quarterly Report
- Notice of Allowance from CIPO for Patent Application
- Cynata Awarded Grant for Coronary Artery Disease Study
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics